HK1063183A1 - New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents - Google Patents

New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents

Info

Publication number
HK1063183A1
HK1063183A1 HK04105895A HK04105895A HK1063183A1 HK 1063183 A1 HK1063183 A1 HK 1063183A1 HK 04105895 A HK04105895 A HK 04105895A HK 04105895 A HK04105895 A HK 04105895A HK 1063183 A1 HK1063183 A1 HK 1063183A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
leukemias
cancers
preparation
treatment
Prior art date
Application number
HK04105895A
Other languages
English (en)
Inventor
Jean-Pierre Robin
Robert Dhal
Freddy Drouye
Jean-Pierre Marie
Nina Radosevic
Julie Robin
Karine Souchaud
Patricia Bataille
Original Assignee
Oncopharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncopharm Corp filed Critical Oncopharm Corp
Publication of HK1063183A1 publication Critical patent/HK1063183A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK04105895A 2000-10-17 2004-08-09 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents HK1063183A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2000/001593 WO2002032904A1 (en) 2000-10-17 2000-10-17 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents

Publications (1)

Publication Number Publication Date
HK1063183A1 true HK1063183A1 (en) 2004-12-17

Family

ID=11003995

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04105895A HK1063183A1 (en) 2000-10-17 2004-08-09 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents

Country Status (13)

Country Link
US (1) US6579869B1 (ja)
EP (1) EP1328527B1 (ja)
JP (1) JP4837233B2 (ja)
CN (1) CN1303084C (ja)
AT (1) ATE319714T1 (ja)
AU (1) AU7940500A (ja)
CA (1) CA2426103A1 (ja)
DE (1) DE60026557T2 (ja)
DK (1) DK1328527T3 (ja)
ES (1) ES2258024T3 (ja)
HK (1) HK1063183A1 (ja)
PT (1) PT1328527E (ja)
WO (1) WO2002032904A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285546B2 (en) * 2000-10-17 2007-10-23 Stragen Pharma S.A. Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
US20020128258A1 (en) * 2001-03-09 2002-09-12 Jean-Pierre Robin Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives
JP2006501199A (ja) * 2002-07-17 2006-01-12 ケムジェネックス・ファーマシューティカルズ・リミテッド ホモハリングトニンを含むセファロタキシンの製剤および投与方法
US7642252B2 (en) 2002-07-22 2010-01-05 Chemgenex Pharmaceuticals, Inc. Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
EP2260041A4 (en) * 2008-03-03 2012-04-25 Sloan Kettering Inst Cancer CEPHALOTAXUS ESTERS, SYNTHESIS METHODS AND USES THEREOF
WO2010103405A2 (en) * 2009-03-11 2010-09-16 Jean-Pierre Robin Process for preparing cephalotaxine esters
CN102304132B (zh) * 2011-07-12 2015-01-28 南开大学 高效高立体选择性半合成三尖杉酯类生物碱的方法
US9676789B2 (en) 2011-08-18 2017-06-13 Hangzhou Bensheng Pharmaceutical Co., Ltd. Aminated derivative of homoharringtonine, preparation method therefor, and application thereof
CN103687859B (zh) * 2011-08-18 2016-08-17 杭州本生药业有限公司 高三尖杉酯碱的胺化衍生物、及其制备方法和应用
CN102675327B (zh) * 2012-03-01 2014-12-10 南开大学 三尖杉酯碱类似物及制备方法和应用
CN104293855A (zh) * 2014-10-15 2015-01-21 中国计量学院 脐孢木霉菌转化株在提高木霉素产量中的应用
US10597401B2 (en) 2015-05-08 2020-03-24 Albany Molecular Research, Inc. Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof
CN106866690B (zh) * 2015-12-10 2019-10-11 南开大学 三尖杉酯类生物碱、其制备方法和用途
CN109111459B (zh) * 2017-06-22 2021-10-29 南华大学 含水杨酸三尖杉碱酯衍生物、制造方法及其用途
CN108378049A (zh) * 2018-05-02 2018-08-10 孙利嫚 一种含有粗榧生物碱和甲氧虫酰肼的农药组合物
TW202421631A (zh) * 2022-09-22 2024-06-01 南開大學 三尖杉酯鹼類衍生物及其藥物組合物、製備方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2776292B1 (fr) * 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese

Also Published As

Publication number Publication date
JP2004511560A (ja) 2004-04-15
CN1474821A (zh) 2004-02-11
EP1328527B1 (en) 2006-03-08
CN1303084C (zh) 2007-03-07
PT1328527E (pt) 2006-06-30
AU7940500A (en) 2002-04-29
DK1328527T3 (da) 2006-07-17
EP1328527A1 (en) 2003-07-23
DE60026557D1 (de) 2006-05-04
ES2258024T3 (es) 2006-08-16
JP4837233B2 (ja) 2011-12-14
ATE319714T1 (de) 2006-03-15
US6579869B1 (en) 2003-06-17
DE60026557T2 (de) 2006-12-28
CA2426103A1 (en) 2002-04-25
WO2002032904A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU7940500A (en) New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents
PT804200E (pt) Uso de derivados de noribogaina para tratamento de dependencia quimica em mamiferos
ES2122456T3 (es) Aminoacidos excitadores sinteticos.
ATE108323T1 (de) Haarbehandlungszusammensetzung, bleichzusammensetzung und zusammensetzung zur modifizierung des haarfarbtones.
IE831384L (en) Benzazepines.
MX9801488A (es) Agentes de filtracion de luz.
GB0021421D0 (en) Compounds
ATE256170T1 (de) Verkapseltes reinigungsmittel
NZ331549A (en) Compounds useful in treating sexual dysfunction
IE45090L (en) N-phosphonomethylene - aminoalkane phosphonic acids.
GB0017988D0 (en) Novel process
TR200200360T2 (tr) Antibakteriyel aktif maddeler.
SE7709913L (sv) Sett att framstella penta peptider
EP0750701A4 (en) Opaque means for paper
TW325463B (en) 4-Aminobenzoylguanidine-derivatives
PT82726A (de) Neue derivate des 1,1,2,2-tetramethyl-1,2-bis-(2-fluor-4-hydroxy-phenyl)-ethans
ES8603971A1 (es) Un metodo para el apresto y el lavado de tintes y-o estampa-dos en materiales textiles que contienen fibras de celulosa
IN171499B (ja)
DE50211559D1 (en) Hydrophilieadditive
TW221443B (ja)
NZ512754A (en) Remedial agent for erectile dysfunction containing a 3(2H)-pyridazinone derivative
MX165848B (es) Un producto de reaccion, un compuesto y un procedimiento para obtener un compuesto
AR248401A1 (es) Un microbiocida de 3-halo-5-halometil-2-oxazolidinona, su preparacion e intermediario 5-halometil-2-oxazolidinona y control de un microorganismo en un sistema acuoso y sobre una superficie.
KR830003386A (ko) 암모니아 질소의 질산화 억제용 토양처리제
ATE252550T1 (de) Ungesättigte oligophenolcyanate

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181017